Neuromuscular diseases Archives -

Capricor Therapeutics’ bid to find a partner for its Duchenne muscular dystrophy (DMD) cell therapy CAP-1002 could get

Capricor preps phase 3 for Duchenne cell therapy as it seeks a partner

https://pharmaphorum.com/news/capricor-preps-phase-3-for-duchenne-cell-therapy-as-it-seeks-a-partner/

The prospects of a new class of Duchenne muscular dystrophy therapies have taken another downturn after Roche abandoned

Roche joins others in dropping myostatin inhibitor for DMD

https://pharmaphorum.com/news/roche-joins-others-in-dropping-myostatin-inhibitor-for-dmd/

The FDA has approved Allergan’s Botox to treat lower-limb spasticity in children, further extending the use of the

Allergan gets FDA okay for paediatric Botox use

https://pharmaphorum.com/news/allergan-gets-fda-okay-for-paediatric-botox-use/

Japan’s Nippon Shinyaku Pharma has filed for approval of its Duchenne muscular dystrophy (DMD) in the US, increasing

NS Pharma steals a march on Sarepta with DMD drug

https://pharmaphorum.com/news/ns-pharma-steals-a-march-on-sarepta-with-dmd-drug/

NMD Summit

Industry’s first dedicated Neuromuscular Drug Development (NMD) Summit

https://pharmaphorum.com/events/industrys-first-dedicated-neuromuscular-drug-development-nmd-summit/

Neuromuscular diseases